Abnormal Chromosome Indicated Outcome for Rare Brain Tumor*
Therapy Can Add Years to Certain Brain Tumor Patient’s Lives*
ImmunoCellular Therapuetics Proves Update on Phase II Clinical Trial of ICT-107 for the Treatment of Glioblastoma*
http://www.marketwatch.com/story/immunocellular-therapeutics-provides-updat e-on-phase-ii-clinical-trial-of-ict-107-for-the-treatment-of-glioblastoma-2 012-01-23
*This communication is not intended as a substitute for professional medical advice and does not provide advice on treatments or conditions for individual patients. All health and treatment decisions must be made in consultation with your physician(s), utilizing your specific medical information. The links set out on this communication are provided for your convenience only. The American Brain Tumor Association does not endorse the information contained on the linked websites or individual(s)/companies/institutions operating these websites.